HCPLive Network


Potential New Target for Neuropathic Pain Therapies
Researchers have identified a compound that reduces the levels of a key enzyme that regulates activity in pain receptors, pointing the way to new therapies for treating some forms of back pain, shingles, and other types of chronic neuropathic pain.
Midlife Hypertension Affects Late-life Blood Pressure, Brain Pathology Link
For older men and women without dementia, the impact of late-life blood pressure on brain pathology varies with their history of midlife hypertension, according to a study published online June 4 in Neurology.
COPD Linked to Increased Risk of Mild Cognitive Decline
Patients with chronic obstructive pulmonary disease are twice as likely to develop mild cognitive impairment.
Newer Dopaminergic Agents for Idiopathic Parkinson
The newer non-ergoline-derived dopaminergic agents appear to cause only minimal endocrine effects when used to treat idiopathic Parkinson’s disease.
No Difference in Stroke Risk Based on Body Mass Index
There is no evidence of an obesity paradox in patients with stroke, suggesting that previous findings were an artifact of selection bias, according to a study published online June 2 in JAMA Neurology.
Claim Denials Expected to Increase
Even with good office procedures, most practices are plagued by claim denials, a hassle that is expected to increase in the coming years, according to an article published May 8 in Medical Economics.
Modifying the Course of Multiple Sclerosis: The Growing Treatment Armamentarium
Mechanisms Behind New Multiple Sclerosis Medications
Neurologist Andrew D. Goodman, MD, FAAN, explains the benefits of the mechanisms behind the new multiple sclerosis medications.
Number of Cancer Survivors Projected to Grow in the US
Factors such as the aging and growth of the population accompanied by improvements in early detection and treatment are expected to contribute to the growth of the number of cancer survivors in the United States, according to research published online June 1 in CA: A Cancer Journal for Clinicians.
Most Physicians Would Forgo Aggressive Treatment
Although physicians regularly recommend high-intensity, aggressive, life-prolonging care for their terminally ill patients, the vast majority would choose to forgo such care for themselves at the end of life, according to a study published online May 28 in PLOS ONE.
More Meds, More Problems in Multiple Sclerosis Patients
Taking more than 5 medications was associated with fatigue and memory problems in multiple sclerosis patients, a new study reports.
American Academy of Neurology 2013 Annual Meeting
PAINWeek 2013
64th American Academy of Neurology Annual Meeting
2012 Annual Meeting of the Consortium of Multiple Sclerosis Centers (CMSC)
The 63rd Annual Meeting of the American Academy of Neurology
PAINWeek 2010
American Academy of Neurology 2009
International Conference on Alzheimer's Disease 2009
American Epilepsy Society 2008
Condition Centers